These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 493812)

  • 41. [HBeAg and anti-HBe in asymptomatic carriers of HBsAg and in various forms of hepatitis and liver cirrhosis].
    Kalinowska B; Nazarewicz-de Mezer T; Krawczyński K
    Przegl Epidemiol; 1984; 38(3):249-56. PubMed ID: 6528039
    [No Abstract]   [Full Text] [Related]  

  • 42. HBV-DNA, HBeAg/anti-HBe serological status in hepatitis B chronic individuals from central Italy.
    Rapicetta M; di Nardo V; Rozera C; Marinucci G; Francisci D; Sarrecchia B; Ricci C; Albertoni F
    Epidemiol Infect; 1990 Jun; 104(3):511-7. PubMed ID: 2347388
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HBsAg subtypes among HBsAg carriers in Okinawa, Japan. Evidence of an important relationship in seroconversion from HBeAg to anti-HBe.
    Noguchi A; Hayashi J; Nakashima K; Hirata M; Ikematsu H; Kashiwagi S
    J Infect; 1994 Mar; 28(2):141-50. PubMed ID: 8034993
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Correlation of HBeAg/anti-HBe, ALT levels, and HBV DNA PCR results in HBsAg-positive patients.
    Ljunggren KK; Nordenfelt E; Kidd A
    J Med Virol; 1993 Apr; 39(4):297-302. PubMed ID: 8492102
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Detection of HBe antigen in sera from HBs antigen asymptomatic carrier and hepatitis patients using polyethylene glycol (PEG).
    Tsuji T; Okada T; Nagashima H
    Gastroenterol Jpn; 1979; 14(3):206-10. PubMed ID: 109343
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of indicators for dane particles.
    Hess G; Arnold W; Meyer zum Buschenfelde KH
    Klin Wochenschr; 1980 Apr; 58(7):371-6. PubMed ID: 7392542
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Hepatitis B virus DNA as a marker of viral multiplication: comparison with HBe antigen and anti-HBe antibody].
    Thiers V; Bouchardeau F; Courouce AM; Tiollais P; Brechot C
    Presse Med; 1986 Jun; 15(26):1219-22. PubMed ID: 2944091
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evolution of HBeAg/anti-HBe status and its relationship to clinical and histological outcome in chronic HBV carriers in childhood.
    Sodeyama T; Kiyosawa K; Akahane Y; Tanaka E; Wada S; Oike Y; Nakamura M; Yoda H; Imai Y; Gibo Y
    Am J Gastroenterol; 1986 Apr; 81(4):239-45. PubMed ID: 3962948
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hepatitis Be antigen and antibody in hepatitis B surface antigen positive blood donors.
    Barr A; Black SH; Burrell CJ; Dow B; Macvarish I
    J Clin Pathol; 1979 Feb; 32(2):132-5. PubMed ID: 108319
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Infectivity in asymptomatic hepatitis B carriers: its correlation with HBeAg/anti-HBe status.
    Cheng NY; Chang JG; Liao ST; Liu JD; Lee LS; Chen PH; Choo KB
    Taiwan Yi Xue Hui Za Zhi; 1989 Feb; 88(2):148-51. PubMed ID: 2769214
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Anti-HBc titer in HBeAg(e-antigen) and anti-HBe(anti-e) positive asymptomatic hepatitis B surface antigen (HBsAG) carriers].
    Hess G; Arnold W; Meyer zum Büschenfelde KH; Purcell RH
    Verh Dtsch Ges Inn Med; 1978; (84):943-5. PubMed ID: 742155
    [No Abstract]   [Full Text] [Related]  

  • 52. An electron microscopic demonstration of immune complexes of hepatitis B e-antigen using colloid gold as a marker.
    Stannard LM; Lennon M; Hodgkiss M; Smuts H
    J Med Virol; 1982; 9(3):165-75. PubMed ID: 7097254
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reaction spectrum of HBe antibodies.
    Babeş VT; Tănase M
    Virologie; 1981; 32(1):3-7. PubMed ID: 7303490
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Incidence of hepatitis B virus DNA and DNA-polymerase in sera of Italian asymptomatic carriers with the serological markers of HBV.
    Carloni G; Delfini C; Colloca S; Alfani E; Taliani G; De Bac C
    Arch Virol; 1986; 87(1-2):97-105. PubMed ID: 3942507
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The relationship of hepatitis B e antigen, DNA polymerase activity, and titer of hepatitis B surface antigen with ongoing liver injury in chronic hepatitis B virus infection.
    Perrillo R; Campbell C; Wellinghoff W; Gelb L
    Am J Gastroenterol; 1982 Jul; 77(7):445-9. PubMed ID: 7091131
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Natural history of hepatitis B virus infection in renal transplant recipients--a fifteen-year follow-up.
    Dusheiko G; Song E; Bowyer S; Whitcutt M; Maier G; Meyers A; Kew MC
    Hepatology; 1983; 3(3):330-6. PubMed ID: 6341196
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A new antigenic determinant on HBsAg. Geographic and subtype distribution and association with HBeAg and anti-HBe.
    Bastiaans MJ; Nath N; Mazzur S
    Vox Sang; 1979; 37(3):129-38. PubMed ID: 91267
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Significance of tests for HBeAg and anti-HBe in HBsAg positive blood donors.
    Dow BC; Macvarish I; Barr A; Crawford RJ; Mitchell R
    J Clin Pathol; 1980 Nov; 33(11):1106-9. PubMed ID: 7440758
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [E/anti-E system and viral hepatitis type B (a review of the literature)].
    Viazov SO; Stakhanova VM; Anan'ev VA
    Vopr Virusol; 1979; (1):5-11. PubMed ID: 84440
    [No Abstract]   [Full Text] [Related]  

  • 60. [HBeAg, anti-HBe and hepatitis].
    Suzuki H
    Nihon Rinsho; 1978 May; Suppl():2158-9. PubMed ID: 691674
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.